Immune Repertoire Decoding

February 8 and  9, 2023
Time: 1–6 pm (ET)

Register Here



February 8-9, 2023

Leading experts will introduce the audience to recent advances in decoding the specific T cell or B cell clonotypes mediating or protecting from disease along with their recognized antigen epitopes in the context of human HLA haplotypes. This information promises to enable next generation clonotype or epitope targeted immunotherapies for cancer, autoimmune or infectious diseases that are both more efficacious and safer than current therapies. Recent advances in single cell sequencing technologies and large-scale HLA tetramer or HLA reporter gene-based epitope library screening technologies have made decoding the "immune synapse" possible. Additional speakers will discuss how they are developing powerful immunotherapies based on decoded immune repertoires.

Organizers: Karsten Sauer, PhD, Vice President, Pre-clinical Research and Development, Cullinan Oncology, Michael Birnbaum, PhD, Associate Professor, Massachusetts Institute of Technology, Cambridge, MA

Registration Fee: $0

Presenters: Catherine Bollard, Children’s National Hospital, Anthony Coyle, Repertoire Immune Medicines, Stephen Elledge, Harvard University, Claude Perreault, University of Montreal, Ivelin Georgiev, Vanderbilt University, Jenny Jiang, University of Pennsylvania, Alessandro Sette, La Jolla Institute for Immunology, Anish Suri, Cue Biopharma, and Mark Yarmarkovich, University of Pennsylvania.


Four abstracts will be selected for lightning talks at the conference. If you would like to be considered for a lightning talk, please email your abstract in an MS Word document including abstract title, abstract content, and author information to Michael Birnbaum, PhD at by February 1.

View the program agenda.